Long-term recovery from a substance use disorder is the ongoing process of managing the condition well after formal treatment ends, marked by clinical milestones that carry real, measurable meaning. In New Hampshire and across the country, that process is not a single finish line but a series of stages, each associated with lower relapse risk and a different set of day-to-day realities. The clinical distinction that matters most is the one drawn in the DSM-5 between early remission, meaning three to twelve months without meeting the criteria for the disorder, and sustained remission, meaning twelve months or more. Programs built around Joint Commission accreditation standards are designed with this full timeline in mind, not just the first weeks after discharge. What happens at 6 months, 1 year, and 5 years is not a straight line of steadily feeling better. It has real texture, and knowing what to expect at each stage makes the in-between parts easier to tolerate.
Six Months: Early Remission and Still Building the Foundation
At six months, someone is in what the DSM-5 classifies as early remission, a real and meaningful clinical milestone, but also the period when relapse risk remains highest. National data from the National Institute on Drug Abuse puts overall relapse rates for substance use disorders at 40 to 60 percent, a rate the agency notes is comparable to relapse rates for other chronic conditions like hypertension and asthma, not evidence that treatment failed. Most of that risk concentrates in the first year, and especially the first six months, which is exactly why aftercare and continued outpatient support matter as much during this window as the initial treatment did.
Practically, six months often looks like new routines that still feel effortful rather than automatic. Triggers that once meant an immediate return to substance use now have some space around them, room to use a coping skill instead, but that space still takes conscious effort to access. Relationships that were damaged during active substance use are often still being rebuilt, sometimes more slowly than the person in recovery would like. This is also frequently when someone steps down from a more intensive level of care, moving from Partial Hospitalization to Intensive Outpatient. Flexible scheduling matters a great deal at this stage: evening and weekend IOP options let someone step down in intensity without stepping away from a job, a class schedule, or family responsibilities.
One Year: Sustained Remission Begins

Reaching twelve months moves someone into what the DSM-5 calls sustained remission, and the data reflects a real shift here too. Relapse risk, while still present, drops noticeably compared to the first six months, particularly for people who have stayed engaged with some form of ongoing support, whether that is continued outpatient therapy, a support group, or regular check-ins with a provider.
A year in, the routines that felt effortful at six months have often become closer to automatic. Coping skills that required conscious thought now happen more reflexively. Relationships have usually made real, visible progress, though full trust often takes longer than a year to rebuild, particularly with a spouse or older children who lived through the years of active substance use. This is also a period where many people scale back the intensity of formal treatment further, sometimes to periodic check-ins or an alumni support group, while continuing whatever medication-assisted treatment or medication management is part of their plan. For people managing a co-occurring mental health condition alongside a substance use disorder, this is also when dual diagnosis care tends to shift from weekly sessions toward more spaced-out check-ins, rather than stopping altogether.
It is worth being direct about something people in recovery already know: reaching one year does not mean relapse risk reaches zero. It means the risk has meaningfully declined, not disappeared, which is why continued engagement with some form of support, even light-touch support, continues to matter through this period.
Five Years: A Different Kind of Stability

By five years, longitudinal research on sustained recovery points to a substantial and lasting shift: relapse rates for people who have maintained recovery this long generally fall below 15 percent, a meaningfully lower baseline than earlier in the timeline. Researchers and clinicians sometimes describe this as a point where recovery becomes less something a person actively manages every day and more something that has become part of who they are, though it never becomes something requiring zero ongoing attention.
At five years, many people describe recovery less as a daily project and more as an established part of their life, alongside work, family, and other ordinary responsibilities. Some become active in supporting others earlier in the process, whether formally as a peer recovery coach or informally within their own family and community. Relationships that took years to rebuild have often reached a new baseline of trust. None of this means the person could stop paying attention entirely. It means the amount of active management required has changed substantially from where it started.
What Doesn’t Have an End Date
Addiction is treated as a chronic condition, not a temporary illness with a cure, for a reason grounded in how it actually behaves over time. Even at five years and beyond, certain things remain part of the picture indefinitely: awareness of personal triggers, particularly during major life stress or transitions, honesty with a support system about cravings if they resurface, and avoidance of situations known to carry high personal risk. This is not a sign that someone hasn’t fully recovered. It is simply how a chronic condition works, the same way someone with well-managed hypertension still checks their blood pressure and still avoids the specific things that make it worse, indefinitely, without that ongoing attention meaning the treatment failed.

This is also why choosing a Joint Commission accredited provider for the initial treatment matters well beyond the treatment itself. The clinical standards behind that accreditation shape whether someone leaves treatment with a realistic relapse prevention plan built for years, not just the weeks immediately following discharge.
Why This Matters During Recovery Month
This has been the theme running through everything Heartfelt has written this Recovery Month: treatment is not a single event with a fixed endpoint, and neither is the life that follows it. Whether someone is six months out, five years out, or has not yet made the first call, the same principle applies. Recovery is built in stages, each one realistically harder than the last one made it look from the outside, and each one still worth reaching. Our family resource hub and earlier article on friendships and sober social connections both cover pieces of what sustains recovery over these longer stretches.
Frequently Asked Questions
How long does it take to be considered “in recovery”?
The DSM-5 distinguishes early remission, three to twelve months without meeting the criteria for a substance use disorder, from sustained remission, twelve months or more. Many people consider themselves in recovery well before reaching either clinical milestone, since recovery is both a clinical status and a personal identity.
Does relapse mean treatment failed?
No. Relapse rates for substance use disorders run 40 to 60 percent nationally, a rate comparable to other chronic conditions like hypertension and diabetes. A relapse is a signal to re-engage with support and adjust the treatment plan, not evidence that recovery is impossible.
When does relapse risk become low enough to stop worrying about it?
Relapse risk decreases substantially over time, generally falling below 15 percent after five years of sustained recovery, but it does not reach zero at any point. Ongoing awareness of personal risk factors remains part of long-term recovery indefinitely.
Do people need ongoing treatment forever?
The intensity of formal treatment typically decreases significantly over the first one to two years, moving from more intensive programs toward lighter-touch support like periodic therapy or peer groups. Some form of ongoing awareness and occasional support tends to remain valuable long-term, even when formal treatment has ended.
What helps most in the years after treatment ends?
Continued engagement with some form of support, whether therapy, a support group, or regular check-ins with a provider, is consistently associated with lower relapse risk. Rebuilding and maintaining stable relationships, along with ongoing awareness of personal triggers, also matter significantly over the long term.
Starting or Continuing Your Recovery Timeline in New Hampshire
Whether you are considering treatment for the first time, supporting a loved one years into their recovery, or somewhere in between, Heartfelt Recovery Centers offers Joint Commission accredited outpatient care with flexible evening and weekend scheduling at our Hudson, New Hampshire location, serving families across Southern New Hampshire and Northern Massachusetts. Contact our team or verify your insurance to talk through what the next stage could look like.
WRITTEN BY
Mitchell Cohen, LICSW, MLADC
Licensed Clinical Social Worker, Master Level Alcohol and Drug Counselor
Mitchell Cohen, LICSW, MLADC, is a licensed clinical social worker and Master Level Alcohol and Drug Counselor at Heartfelt Recovery Centers in Hudson, NH. With over 12 years of experience in outpatient addiction treatment, Mitchell specializes in family systems therapy, relapse prevention planning, and dual diagnosis treatment. He is trained in Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT) and holds advanced certifications in family intervention techniques and trauma-informed care.

MD Mitchell Grant Cohen
Dr. Mitchell G. Cohen is a board-certified Internal Medicine specialist with over 34 years of experience in patient-centered healthcare. A graduate of Hahnemann University School of Medicine, Dr. Cohen completed his internship at the University Health Center of Pittsburgh, where he gained invaluable hands-on experience. He is also a certified addiction specialist, holding membership with the American Society of Addiction Medicine (ASAM).
Currently based in Nashua, NH, Dr. Cohen is affiliated with Saint Joseph Hospital, where he provides comprehensive care focusing on both internal medicine and addiction treatment. His expertise includes prevention, diagnosis, and management of adult diseases, as well as specialized care for individuals facing substance use disorders.
Dr. Cohen is committed to fostering open communication, ensuring his patients are fully informed and empowered to make confident decisions about their health and treatment options.
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen
- MD Mitchell Grant Cohen